Antimicrobial Susceptibility Testing Market by Product (Automated System, Disks, MIC Strips, Media), Method (Dilution, Diffusion), Type (Antibacterial, Antifungal), Application (Clinical, Drug Discovery), End User (Labs, Hospitals) - Global Forecast to 2022
Get in-depth analysis of the COVID-19 impact on the Antimicrobial Susceptibility Testing Market
Benchmarking the rapid strategy shifts of the Top 100 companies in the Antimicrobial Susceptibility Testing Market
Request For Special Pricing[165 Pages Report] The global antimicrobial susceptibility testing market is expected to reach USD 3.47 billion by 2022 from USD 2.71 billion in 2017, at a CAGR of 5.1%.
Helped an emerging IVD vendor to identify USD 130 million of additional revenue opportunities in antimicrobial susceptibility testing market worldwide
Client’s Problem Statement
Our client, a top-20 global antimicrobial susceptibility testing market leader, was interested in assessing the global antimicrobial susceptibility testing (AST) market, by sample type and wanted a deep-dive analysis into the regional market size, by value (USD million) of AST of various sample types (positive blood cultures, urine samples, respiratory tract, abdominal, sterile fluids, wounds, and other samples). The client also wanted to understand the major factors influencing the market (drivers, restraints, opportunities, and challenges) at the regional level.
MnM Approach
Authentic secondary sources such as government websites, annual reports, corporate presentations, proprietary databases as well as MnM repository was browsed through initially to gain an understanding of the market dynamics and trends. MnM then conducted a multi-level, qualitative, and quantitative study with a constructed sample of mid-to-senior level management executives as well as industry professionals from the supply side to understand regional level adoption, the share of subsegments in the overall market, the competitive scenario, and growth prospects. At each level, the data was verified by conducting primary interviews with industry experts (both, from demand and supply sides) across each of the target regions to capture and analyze current and forecast quantitative market information and estimates which was finally analyzed by MarketsandMarkets domain experts to derive an unbiased final output. This helped the global leader gain an in-depth understanding of the major factors influencing the adoption of AST for each sample type (drivers, restraints, opportunities, and challenges). The project provided insights on the current and forecast global and regional market size for antimicrobial susceptibility testing for each sample type. Recommendations provided by MnM helped the client to develop strategies to maximize business growth.
Revenue Impact (RI)
Helped an emerging IVD vendor to identify USD 130 million of additional revenue opportunities in Antimicrobial susceptibility testing market worldwide
By method, the disk diffusion segment is expected account for the largest share
By method, the market is segmented into disk diffusion, dilution, ETEST, automated susceptibility testing, and genotypic methods. The disk diffusion segment is expected to dominate the AST market with a share in 2017. Growth in this segment can largely be attributed to its low cost and the flexible nature of these methods.
The manual antimicrobial susceptibility testing segment is estimated to account for the largest share of the market by product in 2017
The AST market is segmented on the basis of product into automated laboratory instruments, manual antimicrobial susceptibility testing products, culture and growth media, and consumables. The manual antimicrobial susceptibility testing products segment is expected to command the largest share of the global AST market in 2017. The large share of this segment is attributed to the benefits these products offer such as low cost, ease of use, reduced labor cost, and the compatibility of manual susceptibility testing products with a wide range of organisms.
By type, the antibacterial testing segment is expected account for the largest share of the market
The global antimicrobial susceptibility testing market is segmented by type into antibacterial, antifungal, antiparasitic, and other susceptibility testing types (mycobacterium and virus). The antibacterial testing segment dominated the market in 2017. The largest share of this market can be attributed to factors such as increasing prevalence of infections due to bacterial pathogens and increasing guidelines streamlining the process of AST.
By application and hospitals clinical diagnostics segment accounted for the largest share in 2017
By application, the antimicrobial susceptibility testing market is segmented into clinical diagnostics, drug discovery and development, epidemiology, and other applications. The other applications segment includes veterinary diagnostics, bioterrorism surveillance, and environmental monitoring. The clinical diagnostics segment accounted for the largest share in 2017. A number of factors such as the increasing prevalence of infectious diseases, the rising burden of antimicrobial resistance, and growing awareness about the use of antimicrobial susceptibility testing methods for diagnostic applications are responsible for the large market share of this application segment.
Diagnostic laboratories and hospitals are expected to be the largest end users is the antimicrobial susceptibility testing market in 2017
By end user, the market is segmented into diagnostic laboratories and hospitals; pharmaceutical and biotechnology companies; contract research organizations; and research and academic institutes. The hospitals and diagnostic laboratories segment is expected to account for the largest share of the AST market in 2017 due to the increasing prevalence of infectious diseases, rising healthcare expenditure, and increasing number initiatives dedicated towards better antibiotic use.
North America is expected to account for the largest share of the antimicrobial susceptibility testing market during the forecast period
The report covers the antimicrobial susceptibility testing market across four key geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to dominate the global AST market primarily due to easy accessibility and better adoption of technologically advanced susceptibility testing methods and products. The increasing prevalence of antimicrobial resistance in North America is another key factor supporting the growth of this regional segment in the global antimicrobial susceptibility testing market. The Asia Pacific is expected to grow at the fastest CAGR as markets in developed countries are increasingly becoming saturated and manufacturers and suppliers of AST products are shifting their focus towards the Asian market.
Antimicrobial Susceptibility Testing Market, By Region
Market Dynamics
Factors such as increasing prevalence of infectious diseases across the globe, emergence of antimicrobial resistance caused due to drug overuse, increasing initiatives by government organizations towards improving the detection and control antimicrobial resistant species, and improving growth opportunities in emerging markets are boosting the demand for antimicrobial susceptibility testing products.
Driver Rising prevalence of infectious diseases
The demand for clinical microbiology testing techniques has witnessed a steady growth during the last decade owing to the rising prevalence of major infectious diseases. With an expected rise in the global burden of infectious diseases, the demand for clinical microbiology techniques utilized for microbial identification and antimicrobial susceptibility testing against pathogens is expected to witness significant growth during the forecast period. This provides an opportunity for major market players to manufacture microbiology products to cater to ongoing research studies and meet the rising market demand for effective and specific disease diagnostic products across the globe.
Early availability of information on bacterial pathogens and their antimicrobial susceptibility help in the timely adoption of appropriate treatment therapies, thereby playing an important role in disease management.
The growing number of epidemic outbreaks caused by infectious pathogens such as Haemophilus influenzae, Neisseria meningitides, Streptococcus pneumoniae, Shigella, Vibrio cholera, Neisseria gonorrhoeae, and Salmonella serotype Typhi is also propelling the demand for antimicrobial susceptibility testing products. Listed below are WHO statistics regarding the increased incidence of several major infectious diseases in recent years:
- As of March 2016, around 28,646 cases of Ebola virus infections have been reported; key affected countries included the US, the UK, Spain, Italy, Senegal, Nigeria, Mali, Liberia, Guinea, and Sierra Leone.
- In 2016, 10.4 million people across the globe were estimated to be suffering from tuberculosis, of which 1.7 million people died due to the disease.
- In 2015, an estimated 214 million patients were reportedly suffering from malaria globally, with 90% deaths registered in Africa.
- In 2014, globally, ~36.9 million people were reportedly suffering from AIDS, with nearly 2 million new AIDS cases recorded for the same year.
- Globally, an estimated 1.4 to 4 million cases of cholera are reported worldwide.
Infectious diseases caused due to bacterial pathogens such as sepsis, which affects over a million people every year, are developing into a worldwide burden. Performing antibiotic susceptibility tests (ASTs) thus becomes a crucial part of clinical microbiology laboratories. The rapidly growing geriatric population is also leading to an increased susceptibility of individuals towards chronic diseases. According to the WHO, between 2015 and 2050, the world's population (aged 60 years and over) will increase from 12% to reach 22%. Thus, growing prevalence of infectious diseases, coupled with the increased use of antimicrobial drugs to combat causative pathogens, is driving the growth of the antimicrobial susceptibility testing market.
Restraint- Unfavorable reimbursement scenario
Limited availability of medical reimbursements for microbial testing procedures is a major factor that limits the preference for advanced clinical microbiology products among patients and healthcare professionals. This directly affects the adoption of premium-priced antimicrobial products, thereby negatively affecting their market growth. In the US, medical reimbursements are provided by healthcare services coding followed by medical coverage through third-party payers. Healthcare services coding includes CPT codes maintained by the American Medical Association (AMA), which are used in combination with ICD (International Classification of Diseases) codes for patient diagnosis and reimbursements.
Furthermore, updating the existing CPT/ICD codes or allotting a new code is a complex and lengthy process that takes up to 2 years. Even after notification of a new code, insurance coverage for new test procedures may vary by insurer or payment mechanism. In the US, Medicare has a policy to not provide any additional reimbursement for treatment of Hospital Acquired Infections (HAIs), in turn limiting the use of antimicrobial susceptibility testing for HAIs.
Scope of the Report
|
Report Metric |
Details |
|
Market Size Available for Years |
2015–2022 |
|
Base Year Considered |
2016 |
|
Forecast Period |
2017–2022 |
|
Forecast Units |
Value (USD) |
|
Segments Covered |
Method, Product, Type, Application, End User, and Region |
|
Geographies Covered |
North America (US & Canada), Europe, APAC and RoW |
|
Companies Covered |
bioMérieux (France), BD (US), Danaher (US), Thermo Fisher (US), Bio-Rad (US), Hi-Media (India), MERLIN (Germany), Liofilchem (Italy), Accelerate (US), Alifax (Italy), Creative Diagnostics (US), Merck Group(Germany), Synbiosis (UK), Bioanalyse (Turkey), and Zhuhai DL Biotech (China). Major 15 players covered. |
This research report categorizes the antimicrobial susceptibility testing market based on method, product, type, application, end user, and region.
This report categorizes the global AST market into the following segments and subsegments:
Global Antimicrobial Susceptibility Testing Market, By Product
- Automated Laboratory Instruments
- Manual Antimicrobial Susceptibility Testing Products
- Susceptibility Testing Disks
- MIC strips
- Susceptibility Plates
- Culture and Growth Media
- Consumables
Global Antimicrobial Susceptibility Testing Market, By Method
- Dilution
- Disk Diffusion
- ETEST
- Automated Antimicrobial Susceptibility Testing
- Genotypic Methods
Global Antimicrobial Susceptibility Testing Market, By Type
- Antibacterial Testing
- Antifungal Testing
- Antiparasitic Testing
- Others Susceptibility Testing
Note: Others include viruses and fastidious organism testing among others
Global Antimicrobial Susceptibility Testing Market, By Application
- Clinical Diagnostics
- Drug Discovery and Development
- Epidemiology
- Other Applications
Note: Other applications include veterinary diagnostics, Bioterrorism Surveillance, environmental monitoring, research and academic applications,
Global Antimicrobial Susceptibility Testing Market, By End User
- Diagnostic Centers and Hospitals
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Research and Academic Institutes
Global Antimicrobial Susceptibility Testing Markets, By Region
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
Key Market Players:
Prominent players in the antimicrobial susceptibility testing market include bioMérieux (France), BD (US), Danaher (US), Thermo Fisher (US), Bio-Rad (US), Hi-Media (India), MERLIN (Germany), Liofilchem (Italy), Accelerate (US), Alifax (Italy), Creative Diagnostics (US), Merck Group(Germany), Synbiosis (UK), Bioanalyse (Turkey), and Zhuhai DL Biotech (China).
bioMérieux (France) held the leading position in the global antimicrobial susceptibility testing market in 2016. The company offers a comprehensive range of solutions for microbial identification and susceptibility testing. bioMérieux has a broad and balanced geographic footprint, through its strong distribution network of 42 subsidiaries and about 20 R&D centers, which maximizes marketing opportunities for its products. The company is focused on high investment in R&D which is leading to the launch of new and technologically improved products. For instance, in December 2016, the company introduced the ETEST Ceftolazone/Tazobactam strip having MIC reading scale in μg/mL, to check susceptibility of microorganisms to Ceftolozane and Tazobactam antibiotic agents.
Recent Developments:
- In 2017, Thermo Fisher (US) launched Sensititre Gram Negative GN6F Plate for Sensititre ID/AST System.
- In 2017, Alifax (Italy), signed an agreement with AKAB International Investment (UAE), to bring the latest microbiology patent instruments including HB&L-Alfred- Sidecar to the UAE market and cover all the GCC countries.
- In 2016, bioMérieux (France) launched ETEST Ceftolazone/ Tazobactam in the European Market)
- In 2016, Bruker (US) acquired MERLIN Diagnostika GmbH (Germany), to further expand Bruker’s microbiology business.
Key Questions Addressed in the Report
- What are the growth opportunities related to the adoption of antimicrobial susceptibility testing market across major regions in the future?
- Emerging countries have immense opportunities for the growth and adoption of antimicrobial susceptibility testing t. Will this scenario continue in the next five years?
- Where will all the advancements in products offered by various companies take the industry in the mid- to long-term?
- What are the new trends and advancements in the antimicrobial susceptibility testing market?
To know about the assumptions considered for the study, download the pdf brochure
Table of Contents
1 Introduction (Page No. - 15)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. - 19)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Data Triangulation Methodology
2.4 Assumptions for the Study
3 Executive Summary (Page No. - 28)
4 Premium Insights (Page No. - 34)
4.1 Attractive Opportunities in Antimicrobial Susceptibility Testing Market
4.2 Antimicrobial Susceptibility Testing Market, By Method
4.3 Geographic Analysis: Antimicrobial Susceptibility Testing Market, By Region & Product
4.4 Antimicrobial Susceptibility Testing Market, By Type
4.5 Antimicrobial Susceptibility Testing Market, By Application
4.6 Antimicrobial Susceptibility Testing Market, By End User
4.7 Geographical Snapshot Of The Antimicrobial Susceptibility Testing Market
5 Market Overview (Page No. - 40)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Prevalence of Infectious Diseases
5.2.1.2 Increased Funding, Research Grants, and Public-Private Investments
5.2.1.3 Technological Advancements Towards the Development of Rapid Ast Methods
5.2.1.4 Emergence of Multidrug Resistance Due to Drug Abuse
5.2.2 Restraints
5.2.2.1 Unfavorable Reimbursement Scenario
5.2.3 Opportunities
5.2.3.1 Emerging Markets to Offer Lucrative Opportunities
5.2.3.2 Initiatives to Detect and Control Antimicrobial-Resistant Species
5.2.4 Challenges
5.2.4.1 High Cost of Automated Antimicrobial Susceptibility Testing Systems
5.2.4.2 Lack of Coordination Between Regulatory Bodies, Clinical Laboratories, and Ast Manufacturers
5.3 Market Trends
6 Antimicrobial Susceptibility Testing Market, By Method (Page No. - 49)
6.1 Introduction
6.2 Disk Diffusion
6.3 Automated Ast
6.4 Dilution
6.5 Etest
6.6 Genotypic Methods
7 Antimicrobial Susceptibility Testing Market, By Product (Page No. - 57)
7.1 Introduction
7.2 Manual Antimicrobial Susceptibility Testing Products
7.2.1 Susceptibility Testing Disks
7.2.2 Mic Strips
7.2.3 Susceptibility Plates
7.3 Automated Laboratory Instruments
7.4 Culture and Growth Media
7.5 Consumables
8 Antimicrobial Susceptibility Testing Market, By Type (Page No. - 67)
8.1 Introduction
8.2 Antibacterial Susceptibility Testing
8.3 Antifungal Susceptibility Testing
8.4 Antiparasitic Susceptibility Testing
8.5 Other Susceptibility Testing
9 Antimicrobial Susceptibility Testing Market, By Application (Page No. - 74)
9.1 Introduction
9.2 Clinical Diagnostics
9.3 Drug Discovery and Development
9.4 Epidemiology
9.5 Other Applications
10 Antimicrobial Susceptibility Testing Market, By End User (Page No. - 81)
10.1 Introduction
10.2 Diagnostic Laboratories and Hospitals
10.3 Pharmaceutical and Biotechnology Companies
10.4 Research and Academic Institutes
10.5 Contract Research Organizations
11 Antimicrobial Susceptibility Testing Market, By Region (Page No. - 88)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 France
11.3.4 Italy
11.3.5 Spain
11.3.6 RoE
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 South Korea
11.4.5 Australia
11.4.6 RoAPAC
11.5 Latin America
11.5.1 Brazil
11.5.2 Mexico
11.5.3 Rolatam
11.6 Middle East & Africa
12 Competitive Landscape (Page No. - 114)
12.1 Introduction
12.2 Market Share Analysis, 2016
12.3 Competitive Scenario
12.3.1 Product Launches and Enhancements
12.3.2 Acquisitions
12.3.3 Agreements and Collaborations
12.3.4 Expansions
12.4 Vendor Dive Overview
12.5 Vendor Inclusion Criteria
12.6 Vendor Dive
12.6.1 Visionary Leaders
12.6.2 Innovators
12.6.3 Dynamic Differentiators
12.6.4 Emerging Companies
13 Company Profiles (Page No. - 118)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
13.1 Biom¨¦rieux
13.1.1 Business Overview
13.1.2 Products Offered
13.1.3 Recent Developments
13.1.4 MnM View
13.2 Danaher
13.2.1 Business Overview
13.2.2 Products Offered
13.2.3 Recent Developments
13.2.4 MnM View
13.3 BD
13.3.1 Business Overview
13.3.2 Products Offered
13.3.3 Recent Developments
13.3.4 MnM View
13.4 Thermo Fisher
13.4.1 Business Overview
13.4.2 Products Offered
13.4.3 Recent Developments
13.4.4 MnM View
13.5 Bio-Rad
13.5.1 Business Overview
13.5.2 Products Offered
13.5.3 Recent Developments
13.5.4 MnM View
13.6 HI-Media
13.6.1 Business Overview
13.6.2 Products Offered
13.6.3 Recent Developments
13.6.4 MnM View
13.7 Merlin
13.7.1 Business Overview
13.7.2 Products Offered
13.7.3 Recent Developments
13.7.4 MnM View
13.8 Liofilchem
13.8.1 Business Overview
13.8.2 Products Offered
13.8.3 Recent Developments
13.8.4 MnM View
13.9 Accelerate Diagnostics
13.9.1 Business Overview
13.9.2 Products Offered
13.9.3 Recent Developments
13.9.4 MnM View
13.1 Alifax
13.10.1 Business Overview
13.10.2 Products Offered
13.10.3 Recent Developments
13.10.4 MnM View
13.11 Creative Diagnostics
13.11.1 Business Overview
13.11.2 Products Offered
13.11.3 Recent Developments
13.11.4 MnM View
13.12 Merck Group
13.12.1 Business Overview
13.12.2 Products Offered
13.12.3 Recent Developments
13.12.4 MnM View
13.13 Synbiosis
13.13.1 Business Overview
13.13.2 Products Offered
13.13.3 Recent Developments
13.13.4 MnM View
13.14 Bioanalyse
13.14.1 Business Overview
13.14.2 Products Offered
13.14.3 Recent Developments
13.14.4 MnM View
13.15 Zhuhai Dl Biotech
13.15.1 Business Overview
13.15.2 Products Offered
13.15.3 Recent Developments
13.15.4 MnM View
13.16 Other Compnies
13.16.1 Business Overview
13.16.2 Products Offered
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View Might Not Be Captured in Case of Unlisted Companies.
14 Appendix (Page No. - 154)
14.1 Insights Of Industry Experts
14.2 Discussion Guide
14.3 Knowledge Store: Marketsandmarkets¡¯ Subscription Portal
14.4 Introducing RT: Real-Time Market Intelligence
14.5 Available Customizations
14.6 Related Reports
14.7 Author Details
List of Tables (62 Tables)
Table 1 Global Antimicrobial Susceptibility Testing Market, By Method, 2015¨C2022 (USD Million)
Table 2 Global Disk Diffusion Market, By Region, 2015¨C2022 (USD Million)
Table 3 Global Automated Ast Market, By Region, 2015¨C2022 (USD Million)
Table 4 Global Dilution Market, By Region, 2015¨C2022 (USD Million)
Table 5 Global Etest Market, By Region, 2015¨C2022 (USD Million)
Table 6 Global Genotypic Methods Market, By Region, 2015¨C2022 (USD Million)
Table 7 Antimicrobial Susceptibility Testing Market, By Product, 2015¨C2022 (USD Million)
Table 8 Manual Antimicrobial Susceptibility Testing Products Market, By Type, 2015¨C2022 (USD Million)
Table 9 Manual Antimicrobial Susceptibility Testing Products Market, By Region, 2015¨C2022 (USD Million)
Table 10 Susceptibility Testing Disks Market, By Region, 2015¨C2022 (USD Million)
Table 11 Mic Strips Market, By Region, 2015¨C2022 (USD Million)
Table 12 Susceptibility Plates Market, By Region, 2015¨C2022 (USD Million)
Table 13 Automated Laboratory Instruments Market, By Region, 2015¨C2022 (USD Million)
Table 14 Culture and Growth Market, By Region, 2015¨C2022 (USD Million)
Table 15 Consumables Market, By Region, 2015¨C2022 (USD Million)
Table 16 Antimicrobial Susceptibility Testing Market, By Type, 2015¨C2022 (USD Million)
Table 17 Antibacterial Susceptibility Testing Market, By Region, 2015¨C2022 (USD Million)
Table 18 Antifungal Susceptibility Testing Market, By Region, 2015¨C2022 (USD Million)
Table 19 Antiparasitic Susceptibility Testing Market, By Region, 2015¨C2022 (USD Million)
Table 20 Other Susceptibility Testing Market, By Region, 2015¨C2022 (USD Million)
Table 21 Global Market, By Application, 2015¨C2022 (USD Million)
Table 22 Global Market for Clinical Diagnostics, By Region, 2015¨C2022 (USD Million)
Table 23 Global Market for Drug Discovery and Development, By Region, 2015¨C2022 (USD Million)
Table 24 Global Epidemiology Market, By Region, 2015¨C2022 (USD Million)
Table 25 Global Market for Other Applications, By Region, 2015¨C2022 (USD Million)
Table 26 Global Market, By End User, 2015¨C2022 (USD Million)
Table 27 Global Market for Diagnostic Laboratories and Hospitals, By Region, 2015¨C2022 (USD Million)
Table 28 Antimicrobial Susceptibility Testing Market for Pharmaceutical and Biotechnology Companies, By Region, 2015¨C2022 (USD Million)
Table 29 Global Market for Research and Academic Institutes, By Region, 2015¨C2022 (USD Million)
Table 30 Global Market for Cros Market, By Region, 2015¨C2022 (USD Million)
Table 31 Global Market, By Region, 2015¨C2022 (USD Million)
Table 32 North America: Antimicrobial Susceptibility Testing Market, By Country, 2015¨C2022 (USD Million)
Table 33 North America: Market, By Product, 2015¨C2022 (USD Million)
Table 34 North America: Market, By Method, 2015¨C2022 (USD Million)
Table 35 North America: Market, By Type, 2015¨C2022 (USD Million)
Table 36 North America: Market, By Application, 2015¨C2022 (USD Million)
Table 37 North America: Market, By End User, 2015¨C2022 (USD Million)
Table 38 US: Antimicrobial Susceptibility Testing Market, By Product, 2015¨C2022 (USD Million)
Table 39 US: Market, By Method, 2015¨C2022 (USD Million)
Table 40 US: Market, By Type, 2015¨C2022 (USD Million)
Table 41 US: Market, By Application, 2015¨C2022 (USD Million)
Table 42 US: Market, By End User, 2015¨C2022 (USD Million)
Table 43 Canada: Antimicrobial Susceptibility Testing Market, By Product, 2015¨C2022 (USD Million)
Table 44 Canada: Market, By Method, 2015¨C2022 (USD Million)
Table 45 Canada: Market, By Type, 2015¨C2022 (USD Million)
Table 46 Canada: Market, By Application, 2015¨C2022 (USD Million)
Table 47 Canada: Market, By End User, 2015¨C2022 (USD Million)
Table 48 Europe: Antimicrobial Susceptibility Testing Market, By Product, 2015¨C2022 (USD Million)
Table 49 Europe: Market, By Method, 2015¨C2022 (USD Million)
Table 50 Europe: Market, By Type, 2015¨C2022 (USD Million)
Table 51 Europe: Market, By Application, 2015¨C2022 (USD Million)
Table 52 Europe: Market, By End User, 2015¨C2022 (USD Million)
Table 53 Asia Pacific: Antimicrobial Susceptibility Testing Market, By Product, 2015¨C2022 (USD Million)
Table 54 Asia Pacific: Market, By Method, 2015¨C2022 (USD Million)
Table 55 Asia Pacific: Market, By Type, 2015¨C2022 (USD Million)
Table 56 Asia Pacific: Market, By Application, 2015¨C2022 (USD Million)
Table 57 Asia Pacific: Market, By End User, 2015¨C2022 (USD Million)
Table 58 RoW: Antimicrobial Susceptibility Testing Market, By Product, 2015¨C2022 (USD Million)
Table 59 RoW: Market, By Method, 2015¨C2022 (USD Million)
Table 60 RoW: Market, By Type, 2015¨C2022 (USD Million)
Table 61 RoW: Market, By Application, 2015¨C2022 (USD Million)
Table 62 RoW: Market, By End User, 2015¨C2022 (USD Million)
List of Figures (38 Figures)
Figure 1 Global Antimicrobial Susceptibility Testing Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Breakdown of Supply-Side Primary Interviews: By Company Type, Designation, and Region
Figure 4 Data Triangulation
Figure 5 Global Market, By Method, 2017
Figure 6 Manual Antimicrobial Susceptibility Testing Products Will Continue to Hold Largest Share in 2022
Figure 7 Global Market, By Type, 2017 (USD Million)
Figure 8 Antimicrobial Susceptibility Testing Market, By Application, 2017 (USD Million)
Figure 9 Global Market, By End User, 2017 vs 2022 (USD Million)
Figure 10 Asia Pacific Market to Grow at the Highest CAGR During the Forecast Period
Figure 11 Rising Prevalence of Infectious Diseases¡ªMajor Factor Driving Market Growth
Figure 12 Disk Diffusion Segment Will Continue to Dominate the Market in 2022
Figure 13 Manual Antimicrobial Susceptibility Testing Products to Dominate the Global Antimicrobial Susceptibility Testing Market in 2017
Figure 14 Antibacterial Susceptibility Testing Segment Will Continue to Dominate the Market in 2022
Figure 15 Clinical Diagnostics Segment to Account for the Largest Market Share in 2022
Figure 16 Hospitals & Diagnostic Laboratories to Register the Highest Growth Rate in the Forecast Period
Figure 17 Asia Pacific to Witness the Highest CAGR During the Forecast Period
Figure 18 Antimicrobial Susceptibility Testing Market: Drivers, Restraints, Opportunities, and Challenges
Figure 19 Deaths Attributable to Antimicrobial Resistance Per Year By 2050
Figure 20 Disk Diffusion Segment to Dominate the Global Antimicrobial Susceptibility Testing Method Market During the Forecast Period
Figure 21 Manual Antimicrobial Susceptibility Testing Products to Dominate the Market During the Forecast Period
Figure 22 Susceptibility Testing Disks to Dominate the Manual Ast Products Market During the Forecast Period
Figure 23 Antibacterial Testing Segment to Dominate the Antimicrobial Susceptibility Testing Market in 2017
Figure 24 Clinical Diagnostics Segment to Dominate the Global Market in 2017
Figure 25 Diagnostic Laboratories and Hospitals Segment to Dominate the Global Market in 2017
Figure 26 North America: Market Snapshot
Figure 27 Europe: Market Snapshot
Figure 28 Asia Pacific: Market Snapshot
Figure 29 RoW: Market Snapshot
Figure 30 Key Developments By Leading Market Players in the Antimicrobial Susceptibility Testing Market, 2014¨C2017
Figure 31 Biom¨¦rieux Held the Leading Position in the Global Market in 2016
Figure 32 Biom¨¦rieux: Company Snapshot
Figure 33 Danaher: Company Snapshot
Figure 34 BD: Company Snapshot
Figure 35 Thermo Fisher: Company Snapshot
Figure 36 Bio-Rad: Company Snapshot
Figure 37 Accelerate Diagnostics: Company Snapshot
Figure 38 Merck Group: Company Snapshot
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Antimicrobial Susceptibility Testing Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Antimicrobial Susceptibility Testing Market